Brooks Laboratories Ltd
Manpreet Singh Naroo has extensive experience in the pharmaceutical industry, with a focus on quality assurance, regulatory affairs, and technical operations. Manpreet Singh currently holds the position of Director of Technical Operations at Brooks Laboratories Limited since August 2021. Prior to this, they worked as the General Manager - Plant - Technical at Unimarck Pharma (I) Limited from February 2015 to August 2021. Before that, they served as the Technical Head (Quality Assurance, Quality Engineering, CQA & Regulatory Affairs) at a formulation company from September 2009 to January 2015. Manpreet Singh also held roles as Sr Manager / DGM - QA & Regulatory Affairs at Ultratech Pharmaceuticals Limited from July 2008 to September 2009, Manager, QA & Regulatory Affairs at British Oxygen Company (BOC) India Limited from April 2008 to June 2008, and Sr Executive at Ranbaxy Laboratories Limited from October 1992 to April 2008. Throughout their career, Manpreet has demonstrated expertise in implementing quality systems, managing regulatory activities, and ensuring compliance with internal and external standards. Manpreet Singh has experience with various formulations and has been involved in audits and training programs.
Manpreet Singh Naroo completed their Bachelor of Science degree in Physics, Chemistry, and Mathematics from Punjabi University between 1989 and 1992. Later, they pursued a Masters in pharmaceuticals with a Diploma in Pharmaceuticals from the Institute of Chemist in Kolkata, from 2006 to 2007. In 2006, they also completed an MBA in Production and Operation Management from NIM in Mumbai. Finally, between 2008 and 2010, they obtained an MSc degree in Organic Chemistry from Vinayaka Mission's Research Foundation - University.
This person is not in any offices
Brooks Laboratories Ltd
Brooks Laboratories Limited is a pharmaceutical manufacturing company. The Company is engaged in manufacturing of drugs and pharmaceuticals. The Company is a contract manufacturing company for molecules in Injectables and Clavulanic Acid range in tablets and dry syrups. The Company has a range of products catering to critical care segment in parental section, such as Beta Lactam, Cephalosporin and General dry powder Injectables, Ampoules and Liquid vials. Its products include Ampicillin Sodium Injection, Aztreonam for Injection, Cefixime Tablets, Cefixime Oral Suspension, Cefpodoxime Proxetil Tablets, Cefuroxime Axetil Tablets, Cefuroxime Axetil for Oral Suspension, Cefoperazone Injection, Ceftriaxone Injection, Ceftazidime for Injection, Cefuroxime Injection, Meropenem Injection, Doripenem Injection, Aciclovir Intravenous Infusion, Artesunate Injection, Pantoprazole Sodium for Injection and Azithromycin for Injection. It has set up a manufacturing plant at Baddi, Himachal Pradesh.